Related Experiment Videos
Osteosarcoma after bone marrow transplantation for acute lymphoblastic leukemia
Tatsuya Asai1, Akira Myoui, Tetsuho Fujimoto
1Department of Orthopaedics, Osaka University Graduate School of Medicine, Osaka, Japan.
International Journal of Clinical Oncology
|October 29, 2002
Summary
This case report details an extremely rare instance of conventional osteosarcoma developing in a patient three years after undergoing bone marrow transplantation for acute lymphoblastic leukemia. The tumor cells exhibited a p53 gene mutation, highlighting a potential link between prior treatments and secondary malignancies.
Area of Science:
- Oncology
- Hematology
- Genetics
Background:
- A male patient underwent chemotherapy and allogeneic bone marrow transplantation for acute lymphoblastic leukemia at age 9.
- He achieved complete remission and remained disease-free for three years post-transplantation.
Observation:
- The patient developed increasing right knee pain three years after bone marrow transplantation.
- Radiological and histological examinations confirmed conventional osteosarcoma.
Findings:
- The osteosarcoma was treated with intensive chemotherapy and wide local excision.
- Tumor cells harbored a p53 gene mutation in exon 7, absent in patient's skin and blood cells.
- Chemotherapy was completed, though myelosuppression recovery was delayed in some cycles.
Implications:
- This case represents an exceptionally rare occurrence of secondary osteosarcoma following bone marrow transplantation.
- The identified p53 mutation suggests a potential role in the pathogenesis of post-transplantation osteosarcoma.
- Further research is warranted to understand the long-term risks of secondary malignancies after bone marrow transplantation and associated genetic alterations.